AAAAAA

   
Results: 1-9 |
Results: 9
Melanoma and other skin neoplasms
Authors: Schuchter, LM
Citation: Lm. Schuchter, Melanoma and other skin neoplasms, CURR OPIN O, 12(2), 2000, pp. 157-158
Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract
Authors: Schuchter, LM Green, R Fraker, D
Citation: Lm. Schuchter et al., Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract, CURR OPIN O, 12(2), 2000, pp. 181-185
Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: A critique - In Reply
Authors: Hensley, ML Schuchter, LM Winer, EP Meropol, NJ Pfister, D
Citation: Ml. Hensley et al., Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: A critique - In Reply, J CL ONCOL, 18(9), 2000, pp. 2005-2006
Update in oncology
Authors: Schuchter, LM Haller, DG
Citation: Lm. Schuchter et Dg. Haller, Update in oncology, ANN INT MED, 133(8), 2000, pp. 615-621
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination
Authors: Stadtmauer, EA Tsai, DE Sickles, CJ Mick, R Luger, SM Porter, DL Mangan, PA Schuchter, LM Schuster, SJ Loh, EY Magee, DA Sachs, RA Wall, ME Moore, J Buzby, GP Zaleta, E Kamoun, M Silberstein, LE
Citation: Ea. Stadtmauer et al., Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination, MED ONCOL, 16(4), 1999, pp. 279-288
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
Authors: Moore, HCF Mick, R Solin, LJ Sickles, C Mangan, PA Luger, SM Fox, KR Schuchter, LM Loh, E Porter, DL Schuster, S Buzby, GP Glatstein, E Silberstein, LE Stadtmauer, EA
Citation: Hcf. Moore et al., Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy, ANN ONCOL, 10(8), 1999, pp. 929-936
Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma
Authors: Chapman, PB Einhorn, LH Meyers, ML Saxman, S Destro, AN Panageas, KS Begg, CB Agarwala, SS Schuchter, LM Ernstoff, MS Houghton, AN Kirkwood, JM
Citation: Pb. Chapman et al., Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma, J CL ONCOL, 17(9), 1999, pp. 2745-2751
American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants
Authors: Hensley, ML Schuchter, LM Lindley, C Meropol, NJ Cohen, GI Broder, G Gradishar, WJ Green, DM Langdon, RJ Mitchell, B Negrin, R Szatrowski, TP Thigpen, JT Von Hoff, D Wasserman, TH Winer, EP Pfister, DG
Citation: Ml. Hensley et al., American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants, J CL ONCOL, 17(10), 1999, pp. 3333-3355
Breast MR imaging in patients with axillary node metastases and unknown primary malignancy
Authors: Orel, SG Weinstein, SP Schnall, MD Reynolds, CA Schuchter, LM Fraker, DL Solin, LJ
Citation: Sg. Orel et al., Breast MR imaging in patients with axillary node metastases and unknown primary malignancy, RADIOLOGY, 212(2), 1999, pp. 543-549
Risultati: 1-9 |